Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Liver biopsy is the gold standard for diagnosis and staging of fibrosis in patients with NAFLD; however, it is invasive, costly, and may be associated with morbidity and even mortality, so is not su...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
European Medical Journal
2019-09-01
|
| Saila: | European Medical Journal |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.emjreviews.com/hepatology/article/noninvasive-imaging-modalities-in-nonalcoholic-fatty-liver-disease-where-do-we-stand/ |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|